Abstract
In the previous two chapters, I applied the trust-based approach to ethical issues related to protecting human rights (i.e. autonomy and privacy) in research. In this chapter, I will shift the focus away from protection of rights toward the protection of welfare by examining issues related to managing risks to human research subjects.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
National Institutes of Health (2009).
- 2.
These additional protections could be viewed as a form of soft paternalism . See discussion in Chap. 2.
- 3.
In Chap. 9 I will discuss research with vulnerable subjects in more depth.
- 4.
The National Institute of Environmental Health Sciences and the Environmental Protection Agency conduct studies that expose healthy volunteers to air pollution. The purpose of this research is to better understand how pollutants affect the human respiratory system. See Resnik (2007a, b, c, d, 2012b).
- 5.
- 6.
For example, suppose that a hypothetical drug (Drug A) used to treat depression has been shown to be 35% effective as compared to a placebo (29%), with a standard error of 5%. Since the placebo lies outside the standard error, we can say that the drug is barely more effective than the placebo. Suppose that we compare a new drug (Drug B) to Drug A and find that Drug A is 35% effective and drug B is 34% effective, with the same standard error of 5%. Since Drug B is only 5% more effective than the placebo from the earlier trial, this active-control study does not tell us whether Drug B is more effective than a placebo, because its effectiveness is within the standard error. To find out whether B is more effective than a placebo, we would need to conduct a study that includes a placebo control group or initiate a much larger active-controlled study to reduce the standard error.
- 7.
Xenotransplantation is transplantation of tissues or organs across species, e.g. pig-human; a zoonosis is a disease transmitted from a vertebrate animal to a human.
References
Agrawal, M., and E.J. Emanuel. 2003. Ethics of Phase I oncology studies: Reexamining the argument and data. Journal of the American Medical Association 290 (8): 1075–1082.
———. 2008. Phase I oncology research. In The Oxford handbook of clinical research ethics, ed. E.J. Emanuel, C. Grady, R.A. Crouch, R.K. Lie, F.G. Miller, and D. Wendler, 356–366. New York: Oxford University Press.
Appelbaum, P.S., and C.W. Lidz. 2008. The therapeutic misconception. In The Oxford handbook of clinical research ethics, ed. E.J. Emanuel, C. Grady, R.A. Crouch, R.K. Lie, F.G. Miller, and D. Wendler, 633–644. New York: Oxford University Press.
Bell, D.S. 2001. Ethics in diabetic clinical trials. Diabetes Care 24 (3): 606.
Bernstein, D., M. Wanner, L. Borish, G.M. Liss, and Immunotherapy Committee; American Academy of Allergy, Asthma and Immunology. 2004. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001. Journal of Allergy and Clinical Immunology. 113 (6): 1129–1136.
Binik, A. 2014. On the minimal risk threshold in research with children. American Journal of Bioethics 14 (9): 3–12.
Chan S. 2016. 6 hospitalized, one of them brain-dead, after drug trial in France. New York Times, January 15, 2016:B2.
Chiong, W. 2006. The real problem with equipoise. American Journal of Bioethics 6 (4): 37–47.
Council for the International Organizations of Medical Sciences. 2002. International ethical guidelines for biomedical research involving human subjects. Geneva: Council for the International Organizations of Medical Sciences.
———. 2016. International ethical guidelines for health-related research involving humans. Geneva: Council for the International Organizations of Medical Sciences.
Crocco, A., and D. D’Elia. 2007. Adverse reactions during voluntary donation of blood and/or blood components. A statistical-epidemiological study. Blood Transfusion 5 (3): 143–152.
Crocco, I., M. Franchini, G. Garozzo, A.R. Gandini, G. Gandini, P. Bonomo, and G. Aprili. 2009. Adverse reactions in blood and apheresis donors: Experience from two Italian transfusion centres. Blood Transfusion 7 (1): 35–38.
———. 2009. Protection of Human Subjects. 45 CFR 46.
Department of Homeland Security, Department of Agriculture, Department of Energy, National Aeronautics and Space Administration, Department of Commerce; Social Security Administration, Agency for International Development; Department of Housing and Urban Development, Department of Labor, Department of Defense, Department of Education, Department of Veterans Affairs, Environmental Protection Agency, Department of Health and Human Services, and National Science Foundation; and Department of Transportation. 2017. Federal policy for the protection of human subjects. Federal Register 82 (12): 7149–7274.
DuVal, G. 2004. Ethics in psychiatric research: Study design issues. Canadian Journal of Psychiatry 49 (1): 55–59.
Earman, J. 1992. Bayes of bust? A critical examination of Bayesian confirmation theory. Cambridge, MA: M.I.T. Press.
Emanuel, E.J., and F.G. Miller. 2001. The ethics of placebo-controlled trials—A middle ground. New England Journal of Medicine 345 (12): 915–919.
Emanuel, E.J., G. Bedarida, K. Macci, N.B. Gabler, A. Rid, and D. Wendler. 2015. Quantifying the risks of non-oncology phase I research in healthy volunteers: Meta-analysis of phase I studies. British Medical Journal 350: h3271.
Evans, R.W. 1998. Complications of lumbar puncture. Neurologic Clinics 16 (1): 83–105.
Freedman, B. 1987. Equipoise and the ethics of clinical research. New England Journal of Medicine 317 (3): 141–145.
Freedman, B., A. Fuks, and C. Weijer. 1993. In loco parentis. Minimal risk as an ethical threshold for research upon children. Hastings Center Report 23 (2): 13–19.
Fried, C. 1974. Medical experimentation: Personal integrity and social policy. New York: Elsevier Publishing.
Friedman, L.W., and E.B. Schron. 2008. Data and safety monitoring boards. In The Oxford handbook of clinical research ethics, ed. E.J. Emanuel, C. Grady, R.A. Crouch, R.K. Lie, F.G. Miller, and D. Wendler, 569–576. New York: Oxford University Press.
Froehlich, F., J.J. Gonvers, J.P. Vader, R.W. Dubois, and B. Burnand. 1999. Appropriateness of gastrointestinal endoscopy: Risk of complications. Endoscopy 31 (8): 684–686.
Gifford, F. 2000. Freedman’s ‘clinical equipoise’ and ‘sliding-scale all-dimensions-considered equipoise’. Journal of Medicine and Philosophy 25 (4): 399–426.
Goodyear, M. 2006. Learning from the TGN1412 Trial. British Medical Journal 332 (7543): 677–688.
Grady, C., and C. Denny. 2008. Research involving women. In The Oxford handbook of clinical research ethics, ed. E.J. Emanuel, C. Grady, R.A. Crouch, R.K. Lie, F.G. Miller, and D. Wendler, 407–422. New York: Oxford University Press.
Green, L.A., J.C. Lowery, C.P. Kowalski, and L. Wyszewianski. 2006. Impact of institutional review board practice variation on observational health services research. Health Services Research 41 (1): 214–230.
Gupta, A., J.S. Mathad, S.M. Abdel-Rahman, J.D. Albano, R. Botgros, V. Brown, R.S. Browning, L. Dawson, K.E. Dooley, D. Gnanashanmugam, B. Grinsztejn, S. Hernandez-Diaz, P. Jean-Philippe, P. Kim, A.D. Lyerly, M. Mirochnick, L.M. Mofenson, G. Montepiedra, J. Piper, L. Sahin, R. Savic, B. Smith, H. Spiegel, S. Swaminathan, D.H. Watts, and A. White. 2016. Toward earlier inclusion of pregnant and postpartum women in tuberculosis drug trials: Consensus statements from an international expert panel. Clinical Infectious Diseases 62 (6): 761–769.
Hellman, S., and D. Hellman. 1991. Of mice but not men: Problems of the randomized clinical trial. New England Journal of Medicine 324 (2): 185–189.
Hunter, D. 2007. Proportional ethical review and the identification of ethical issues. Journal of Medical Ethics 33 (4): 241–245.
Insurance Information Institute. 2016. Mortality risk. Available at: http://www.iii.org/fact-statistic/mortality-risk. Accessed 11 Aug 2017.
Jenkins, K., and A.B. Baker. 2003. Consent and anaesthetic risk. Anaesthesia 58: 962–984.
Joffe, S., and R. Truog. 2008. Equipoise and randomization. In The Oxford textbook of clinical research ethics, ed. E. Emanuel, C. Grady, R. Crouch, R. Lie, F. Miller, and D. Wendler, 245–260. New York: Oxford University Press.
Kimmelman, J. 2004. Valuing risk: The ethical review of clinical trial safety. Kennedy Institute of Ethics Journal 14 (3): 369–393.
King, N.M. 2000. Defining and describing benefit appropriately in clinical trials. Journal of Law, Medicine & Ethics 28 (4): 332–343.
Kopelman, L.M. 1981. Estimating risk in human research. Clinical Research 29 (1): 1–8.
———. 2000. Children as research subjects: A dilemma. Journal of Medicine and Philosophy 25 (6): 745–764.
Laughren, T.P. 2001. The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: An FDA perspective. European Psychiatry 16 (7): 418–423.
Levine, R.J. 1988. Ethics and the regulation of clinical research. 2nd ed. New Haven: Yale University Press.
Li, G., M. Warner, B.H. Lang, L. Huang, and L.S. Sun. 2009. Epidemiology of anesthesia-related mortality in the United States, 1999–2005. Anesthesiology 110 (4): 759–765.
Litton, P., and F.G. Miller. 2005. A normative justification for distinguishing the ethics of clinical research from the ethics of medical care. Journal of Law, Medicine & Ethics 33 (3): 566–574.
London, A.J. 2006. Reasonable risks in clinical research: A critique and a proposal for the integrative approach. Statistics in Medicine 25 (17): 2869–2885.
Lurie, P., and S.M. Wolfe. 1997. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. New England Journal of Medicine 337 (12): 853–856.
Lyerly, A.D., M.O. Little, and R. Faden. 2008. The second wave: Toward responsible inclusion of pregnant women in research. International Journal of Feminist Approaches Bioethics 1 (2): 5–22.
Lyerly, A.D., M.O. Little, and R.R. Faden. 2011. Reframing the framework: Toward fair inclusion of pregnant women as participants in research. American Journal of Bioethics 11 (5): 50–52.
Marquis, D. 1983. Leaving therapy to chance. Hastings Center Report 13 (4): 40–47.
———. 2002. Risk and responsibility: Ethics, Grimes v Kennedy Krieger, and public health research involving children. American Journal of Public Health 92 (7): 1073–1076.
Melo, H., C. Brandao, G. Rego, and R. Nunes. 2001. Ethical and legal issues in xenotransplantation. Bioethics 15 (5-6): 427–442.
Miller, M. 2000. Phase I cancer trials: A collusion of misunderstanding. Hastings Center Report 30 (4): 34–43.
Miller, F.G. 2003. Sham surgery: An ethical analysis. American Journal of Bioethics 3 (4): 41–48.
———. 2008a. Research on medical records without informed consent. Journal of Law, Medicine & Ethics 36 (3): 560–566.
———. 2008b. The ethics of placebo-controlled trials. In The Oxford handbook of clinical research ethics, ed. E.J. Emanuel, C. Grady, R.A. Crouch, R.K. Lie, F.G. Miller, and D. Wendler, 261–272. New York: Oxford University Press.
Miller, F.G., and H. Brody. 2002. What makes placebo-controlled trials unethical? American Journal of Bioethics 2 (2): 3–9.
———. 2003. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Center Report 33 (3): 9–28.
Miller, F.G., and S. Joffe. 2009. Limits to research risks. Journal of Medical Ethics 35 (7): 445–449.
———. 2011. Equipoise and the dilemma of randomized clinical trials. New England Journal of Medicine 364 (5): 476–480.
Miller, P.B., and C. Weijer. 2003. Rehabilitating equipoise. Kennedy Institute of Ethics Journal 13 (2): 93–118.
———. 2006. Fiduciary obligation in clinical research. Journal of Law, Medicine & Ethics 34 (2): 424–440.
Miller, F.G., and A. Wertheimer. 2007. Facing up to paternalism in research ethics. Hastings Center Report 37 (3): 24–34.
National Bioethics Advisory Commission. 1998. Research involving persons with mental disorders that may affect decisionmaking capacity. Washington, DC: National Bioethics Advisory Commission.
———. 2001a. Ethical and policy issues in research involving human participants. Washington, DC: National Bioethics Advisory Commission.
National Commission for the Protection of Human Subjects of Biomedical or Behavioral Research. 1979. The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. Washington, DC: Department of Health, Education, and Welfare.
National Health and Nutrition Examination Survey. 2007. Oral Glucose Tolerance Test (OGTT) procedures manual. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/manual_ogtt.pdf. Accessed 11 Aug 2017.
National Heart, Lung, and Blood Institute. 2016a. Bronchoscopy. Available at: https://www.nhlbi.nih.gov/health/health-topics/topics/bron. Accessed 11 Aug 2017.
National Heart, Lung, and Blood Institute. 2016b. What is atherosclerosis? Available at: http://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis. Accessed 11 Aug 2017.
———. 2009. Clinical Center, medical administrative series, M95-9 (June 5 2009 revision): Guidelines for limits of blood drawn for research purposes in the clinical center. Available at: https://irb.research.chop.edu/sites/default/files/documents/g_nih_blooddraws.pdf. Accessed 11 Aug 2017.
Nuremberg Code. 1949. Trials of war criminals before the Nuremberg military tribunals under Control Council Law No. 10. Vol. 2, 181–182. Washington, DC: U.S. Government Printing Office.
Office of Human Research Protections. 1998. OHRP expedited review categories. Available at: http://www.hhs.gov/ohrp/policy/expedited98.html. Accessed 11 Aug 2017.
Parasidis, E. 2001. Compensation for research-related injuries involving human participants. Harvard Journal on Medical Ethics 2: 26–33.
Pike, E.R. 2012. Recovering from research: A no-fault proposal to compensate injured research participants. American Journal of Law and Medicine 38 (1): 7–62.
———. 2014. In need of remedy: US policy for compensating injured research participants. Journal of Medical Ethics 40 (3): 182–185.
Pue, C.A., and E.R. Pacht. 1995. Complications of fiberoptic bronchoscopy at a university hospital. Chest 107 (2): 430–432.
Rawls, J. 1971. A theory of justice. Cambridge, MA: Harvard University Press.
———. 2005a. Eliminating the daily life risks standard from the definition of minimal risk. Journal of Medical Ethics 31 (1): 35–38.
———. 2006. Compensation for research-related injuries. Ethical and legal issues. Journal of Legal Medicine 27 (3): 263–287.
———. 2007a. The price of truth: How money affects the norms of science. New York: Oxford University Press.
———. 2007b. The new EPA regulations for protecting human subjects: Haste makes waste. Hastings Center Report 37 (1): 17–21.
———. 2007c. Are the new EPA regulations concerning intentional exposure studies involving children overprotective? IRB 29 (5): 15–19.
———. 2007d. Intentional exposure studies of environmental agents on human subjects: Assessing benefits and risks. Accountability in Research 14 (1): 35–55.
———. 2009a. The clinical investigator-subject relationship: A contextual approach. Philosophy, Ethics, and Humanities in Medicine 4: 16.
———. 2012a. Environmental health ethics. Cambridge: Cambridge University Press.
———. 2012b. Ethical virtues in scientific research. Accountability in Research 19 (6): 329–343.
———. 2012c. Limits on risks for healthy volunteers in biomedical research. Theoretical Medicine and Bioethics 33 (2): 137–149.
———. 2012d. Responsible conduct in nanomedicine research: Environmental concerns beyond the common rule. Journal of Law, Medicine & Ethics 40 (4): 848–855.
———. 2013. What is a reasonably foreseeable risk? The SUPPORT study controversy. Journal of Clinical Research Best Practices 9 (8.) Available at: http://www.firstclinical.com/journal/2013/1308_SUPPORT.pdf.
———. 2015b. Bioethical issues in providing financial incentives to research participants. Medicolegal and Bioethics 5: 35–41.
———. 2015c. Unequal treatment of human research subjects. Medicine, Health Care, and Philosophy 18 (1): 23–32.
Resnik, D.B., and R.R. Sharp. 2006. Protecting third parties in human subjects research. IRB 28 (4): 1–7.
Resnik, D.B., and S. Wing. 2007. Lessons learned from the Children’s Environmental Exposure Research Study. American Journal of Public Health 97 (3): 414–418.
Resnik, D.B., and D.C. Zeldin. 2008. Environmental health research on hazards in the home and the duty to warn. Bioethics 22 (4): 209–217.
Resnik, D.B., E. Parasidis, K. Carroll, J.M. Evans, E.R. Pike, and G.E. Kissling. 2014. Research-related injury compensation policies of U.S. research institutions. IRB 36 (1): 12–19.
Rich, W., N.N. Finer, M.G. Gantz, N.S. Newman, A.M. Hensman, E.C. Hale, K.J. Auten, K. Schibler, R.G. Faix, A.R. Laptook, B.A. Yoder, A. Das, S. Shankaran, and SUPPORT and Generic Database Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. 2012. Enrollment of extremely low birth weight infants in a clinical research study may not be representative. Pediatrics 129 (3): 480–484.
Richardson, H.S., and L. Belsky. 2004. The ancillary-care responsibilities of medical researchers. An ethical framework for thinking about the clinical care that researchers owe their subjects. Hastings Center Report 34 (1): 25–33.
Rid, A., and D. Wendler. 2011. A framework for risk-benefit evaluations in biomedical research. Kennedy Institute of Ethics Journal 21 (2): 141–179.
Rid, A., E.J. Emanuel, and D. Wendler. 2010. Evaluating the risks of clinical research. Journal of the American Medical Association 304 (13): 1472–1479.
Rothman, K., and K. Michels. 1994. The continuing unethical use of placebo controls. New England Journal of Medicine 331 (6): 394–398.
Sackett, D., W. Richardson, W. Rosenberg, and R. Haynes. 1997. Evidence-based medicine. New York: Churchill Livingstone.
Schmid, M.W. 2000. Risks and complications of peripherally and centrally inserted intravenous catheters. Critical Care Nursing Clinics of North America 12 (2): 165–174.
Schmidt, M.H., J. Marshall, J. Downie, and M.R. Hadskis. 2011. Pediatric magnetic resonance research and the minimal-risk standard. IRB 33 (5): 1–6.
Scott, L.D. 2003. Research-related injury: Problems and solutions. Journal of Law, Medicine & Ethics 31 (3): 419–428.
Shah, S., A. Whittle, B. Wilfond, G. Gensler, and D. Wendler. 2004. How do institutional review boards apply the federal risk and benefit standards for pediatric research? Journal of the American Medical Association 291 (4): 476–482.
Shamoo, A.E., and T.J. Keay. 1996. Ethical concerns about relapse studies. Cambridge Quarterly of Healthcare Ethics 5 (3): 373–386.
Shrader-Frechette, K.S. 1991. Risk and rationality: Philosophical foundations for populist reforms. Berkeley: University of California Press.
Simon, G.E., and M. VonKorff. 1998. Suicide mortality among patients treated for depression in an insured population. American Journal of Epidemiology 147 (2): 155–160.
Stahl, D.L., K.M. Richard, and T.J. Papadimos. 2015. Complications of bronchoscopy: A concise synopsis. International Journal of Critical Illness and Injury Science 5 (3): 189–195.
Steinbrook, R. 2006. Compensation for injured research subjects. New England Journal of Medicine 354 (18): 1871–1873.
Stuart, R.J., Jr., and M.H. Ellestad. 1980. National survey of exercise stress testing facilities. Chest 77 (1): 94–97.
Suratt, P.M., J.F. Smiddy, and B. Gruber. 1976. Deaths and complications associated with fiberoptic bronchoscopy. Chest 69 (6): 747–751.
Tavris, D.R., B.A. Gallauresi, S. Dey, R. Brindis, and K. Mitchel. 2007. Risk of local adverse events by gender following cardiac catheterization. Pharmacoepidemiology and Drug Safety 16 (2): 125–131.
Temple, R., and S.S. Ellenberg. 2000. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Annals of Internal Medicine 133 (6): 455–463.
Thomas, S.R., D.R. Jamieson, and K.W. Muir. 2000. Randomised controlled trial of atraumatic versus standard needles for diagnostic lumbar puncture. British Medical Journal 321 (7267): 986–990.
United States Bureau of Labor Statistics. 2015. Census of fatal occupational injuries. Available at: https://www.bls.gov/news.release/cfoi.toc.htm. Accessed 11 Aug 2017.
United States Constitution. 1789. Available at: https://www.constituteproject.org/constitution/United_States_of_America_1992. Accessed 11 Aug 2017.
Varmus, H., and D. Satcher. 1997. Ethical complexities of conducting research in developing countries. New England Journal of Medicine 337 (14): 1003–1005.
Wald, M.L. 2010. When a cancer therapy puts others at risk. New York Times, October 24, 2010:A14.
Wang, Y., D. Simar, K. Anderberg, Y. Mavros, S. Kay, R. Zhao, B.T. Baune, A. O’Sullivan, N. Singh, and M.F. Singh. 2011. Muscle and adipose tissue biopsy in older adults with type 2 diabetes. Journal of Diabetes Mellitus 1 (3): 27–35.
Weiss, P.A. 2011. Introductory statistics. 9th ed. Upper Saddles River: Pearson.
Wendler, D., and F.G. Miller. 2007. Assessing research risks systematically: The net risks test. Journal of Medical Ethics 33 (8): 481–486.
———. 2008b. Risk-benefit analysis and the net risks test. In The Oxford handbook of clinical research ethics, ed. E.J. Emanuel, C. Grady, R.A. Crouch, R.K. Lie, F.G. Miller, and D. Wendler, 503–513. New York: Oxford University Press.
Wendler, D., L. Belsky, K.M. Thompson, and E.J. Emanuel. 2005. Quantifying the federal minimal risk standard: Implications for pediatric research without a prospect of direct benefit. Journal of the American Medical Association 294 (7): 826–832.
———. 2011. Rethinking the ethics of clinical research: Widening the lens. New York: Oxford University Press.
———. 2013. Declaration of Helsinki: Ethical principles for medical research involving human subjects (2013 revision). Available at: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed 27 July 2017.
X-Ray Risk. 2016. Available at: http://www.xrayrisk.com/calculator/calculator.php. Accessed 11 Aug 2017.
Yarborough, M., and R.R. Sharp. 2009. Public trust and research a decade later: What have we learned since Jesse Gelsinger’s death? Molecular Genetics and Metabolism 97 (1): 4–5.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Resnik, D.B. (2018). Risks. In: The Ethics of Research with Human Subjects. International Library of Ethics, Law, and the New Medicine, vol 74. Springer, Cham. https://doi.org/10.1007/978-3-319-68756-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-68756-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68755-1
Online ISBN: 978-3-319-68756-8
eBook Packages: Religion and PhilosophyPhilosophy and Religion (R0)